Exposure to High-Risk Genital Human Papillomavirus and Its Association with Risky Sexual Practices and Laboratory-Confirmed Chlamydia Among African-American Women

Women's Health Issues

Volumn 19, Issue 5, 2009, Pages 344-351

  Seth, Puja ^a,b   Wingood, Gina M ^a,b   Robinson, LaShun S ^a   DiClemente, Ralph J ^a,b,c  

^a EMORY UNIVERSITY   (United States)

^b EMORY CENTER FOR AIDS RESEARCH   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; CHLAMYDIA; CHLAMYDIASIS; CONDOM; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; EDUCATION PROGRAM; FEMALE; HEALTH BEHAVIOR; HEALTH EDUCATION; HIGH RISK BEHAVIOR; HUMAN; INFECTION PREVENTION; INFECTION RISK; LABORATORY TEST; MAJOR CLINICAL STUDY; NONHUMAN; PREVALENCE; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; WART VIRUS;

ADOLESCENT; ADULT; AFRICAN AMERICANS; ALPHAPAPILLOMAVIRUS; CHLAMYDIA INFECTIONS; FEMALE; GEORGIA; HUMANS; INTERVIEWS AS TOPIC; SEXUALLY TRANSMITTED DISEASES; UNSAFE SEX; YOUNG ADULT;

EID: 69549114281     PISSN: 10493867     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.whi.2009.06.001     Document Type: Article

References (54)

1. Ault K.A. Effect of prophylactic human papillomavirus L1 virus-like particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: A combined analysis of 4 randomised clinical trials. Lancet 369 (2007) 1861-1868
2. Brown D.R., Legge D., and Qadadri B. Distribution of human papillomavirus types in cervicovaginal washings from women evaluated in a sexually transmitted diseases clinic. Sexually Transmitted Diseases 29 (2002) 763-768
3. Brown D.R., Shew M.L., Qadadri B., Neptune N., Vargas M., Tu W., et al. A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women. Journal of Infectious Diseases 191 (2005) 182-192
4. Burk R.D., Ho G.Y., Beardsley L., Lempa M., Peters M., and Bierman R. Sexual behavior and partner characteristics are the predominant risk factors for genital human papillomavirus infection in young women. Journal of Infectious Diseases 174 (1996) 679-689
5. Cabana M.D., Rand C.S., Powe N.R., Wu A.W., Wilson M.H., Abboud P.A.C., et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. Journal of the American Medical Association 282 (1999) 1458-1465
6. Carpiano R.M., Flocke S.A., Frank S.H., and Stange K.C. Tools, teamwork, and tenacity: An examination of family practice office system influences on preventive service delivery. Preventive Medicine 36 (2003) 131-140
7. Chao C., Slezak J.M., Coleman K.J., and Jacobsen S.J. Papanicolaou screening behavior in mothers and human papillomavirus vaccine uptake in adolescent girls. American Journal of Public Health 99 (2009) 1137-1142
8. Datta S.D., Koutsky L.A., Ratelle S., Unger E.R., Shlay J., McClain T., et al. Human papillomavirus infection and cervical cytology in women screened for cervical cancer in the United States, 2003-2005. Annals of Internal Medicine 148 (2008) 493-500
9. DiClemente R.J., and Wingood G.M. A randomized controlled trial of an HIV sexual risk-reduction intervention for young African American women. JAMA 274 (1995) 1271-1276
10. Division of STD Prevention. (1999). Prevention of genital HPV infection and sequelae: Report of an External Consultants' Meeting. Atlanta: Department of Health and Human Services, Centers for Disease Control and Prevention.
11. Dunne E.F., Unger E.R., Sternberg M., McQuillan G., Swan D.C., Patel S.S., et al. Prevalence of HPV infection among females in the United States. The Journal of the American Medical Association 297 (2007) 813-819
12. Goldie S.J., Grima D., Kohli M., Wright T.C., Weinstein M., and Franco E.A. A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine. International Journal of Cancer 106 (2003) 896-904
13. Gravitt P., Lacey J., Brinton L., Barnes W.A., Kornegay J.R., Greenberg M.D., et al. Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reaction. Cancer Epidemiology Biomarkers and Prevention 10 (2001) 95-100
14. Gravitt P.E., Peyton C.L., Alessi T.Q., Wheeler C.M., Coutlee F., Hildesheim A., et al. Improved amplification of genital human papillomavirus. Journal of Clinical Microbiology 38 (2000) 357-361
15. Gravitt P.E., Peyton C.L., Apple R.J., and Wheeler C.M. Genotyping of 27 HPV types from L1 consensus PCR products using a single hybridization, reverse-line blot detection method. Journal of Clinical Microbiology 36 (1998) 3020-3027
16. Harper D.M., Franco E.L., Wheeler C.M., Moscicki A.B., Romanowski B., Roteli-Martins C.M., et al. Sustained efficacy up to 4.5 years of bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: Follow-up from a randomised control trial. Lancet 367 (2006) 1247-1255
17. Ho G.Y., Bierman R., Beardsley L., Chang C.J., and Burk R.D. Natural history of cervicovaginal papillomavirus infection in young women. New England Journal of Medicine 338 (1998) 423-428
18. Hogewoning C.J.A., Bleeker M.C.G., Van Den Brule A.J.C., Voorhorst F.J., Snijders P.J.F., Berkhof J., et al. Condom use promotes regression of cervical intraepithelial neoplasia and clearance of human papillomavirus: A randomized clinical trial. International Journal of Cancer 107 (2003) 811-816
19. Hosmer D.W., and Lemeshow S. Applied Logistic Regression (1989), John Wiley & Sons, New York
20. Hosmer D.W., Taber S., and Lemeshow S. The importance of assessing the fit of logistic regression models: A case study. American Journal of Public Health 81 (1992) 1630-1635
21. Hutchinson D.J., and Klein K.C. Human papillomavirus disease and vaccines. American Journal of Health-System Pharmacy 65 (2008) 2105-2112
22. Kahn J.A., Lan D., and Kahn R.S. Sociodemographic factors associated with high risk human papillomavirus infection. Obstetrics & Gynecology 110 (2007) 87-95
23. Kaiser Permanente. (2008). 2009 Medicare Part D formulary. Available: https://prospectivemembers.kaiserpermanente.org. Accessed June 8, 2009.
24. Keating K.M., Brewer N.T., Gottlieb S.L., Liddon N., Ludema C., and Smith J.S. Potential barriers to HPV vaccine provision among medical practices in an area with high rates of cervical cancer. Journal of Adolescent Health 43 (2008) S61-S67
25. Kempe A., Daley M.F., Parashar U.D., Crane L.A., Beaty B.L., Stokley S., et al. Will pediatricians adopt the new rotavirus vaccine?. Pediatrics 119 (2007) 1-10
26. Kjaer S.K., Svare E.L., Worm A.M., Wallboomers J.M., Meijer C.J., and van den Brule A.J. Human papillomavirus infection in Danish female sex workers: Decreasing prevalence with age despite continuously high sexual activity. Sexually Transmitted Diseases 27 (2000) 438-445
27. Kjaer S.K., van den Brule A.J., Bock J.E., Poll P.A., Engholm G., Sherman M.E., et al. Determinants for genital human papillomavirus (HPV) infection in 1000 randomly chose young Danish women with normal Pap smear: Are there different risk profiles for oncogenic and nononcogenic HPV types?. Cancer Epidemiology, Biomarkers, and Prevention 6 (1997) 799-805
28. Koutsky L.A. Epidemiology of genital human papillomavirus infection. American Journal of Medicine 102 (1997) 3-8
29. Manhart L.E., Holmes K.K., Koutsky L.A., Wood T.R., Kenney D.L., Feng Q., et al. Human papillomavirus infection among sexually active young women in the United States: Implications for developing a vaccination strategy. Sexually Transmitted Diseases 33 (2006) 502-508
30. Manhart L.E., and Koutsky L.A. Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis. Sexually Transmitted Diseases 29 (2002) 725-735
31. Markowitz L.E., Dunne E.F., Saraiya M., Lawson H.W., Chesson H., and Unger E.R. Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 56 (2007) 1-24
32. McInerny T.K., Cull W.L., and Yudkowsky B.K. Physician reimbursement levels and adherence to American Academy of Pediatrics well-visit and immunization recommendations. Pediatrics 115 (2005) 833-838
33. Middleman A.B. Adolescent immunizations: Policies to provide a shot in the arm for adolescents. Journal of Adolescent Health 41 (2007) 109-118
34. Molano M., Posso H., Weiderpass E., Van Den Brule A.J.C., Ronderos M., Franceschi S., et al. Prevalence and determinants of HPV infection among Colombian women with normal cytology. British Journal of Cancer 87 (2002) 324-333
35. Moscicki A.B., Burt V.G., Kanowitz S., Darragh T., and Shiboski S. The significance of squamous metaplasia in the development of low grade squamous intraepithelial lesions in young women. Cancer 85 (1999) 1139-1144
36. Moscicki A.B., Ellenberg J.H., Farhat S., and Xu J. Persistence of human papillomavirus infection in HIV-infected and -uninfected adolescent girls: Risk factors and differences, by phylogenetic type. Journal of Infectious Diseases 190 (2004) 37-45
37. Paavonen J., Jenkins D., Bosch F., Naud P., Salmeron C., Wheeler S., et al. Efficacy of a prophylactic adjuvant bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: An interim analysis of a phase III double-blind, randomized controlled trial. Lancet 369 (2007) 2161-2170
38. Paavonen J., and Lehtinen M. Introducing human papillomavirus vaccines-questions remain. Annals of Medicine 40 (2008) 162-166
39. Revzina N.V., and DiClemente R.J. Prevalence and incidence of human papillomavirus infection in women in the USA: A systematic review. International Journal of STD and AIDS 16 (2005) 528-537
40. Scarinci I.C., Garces-Palacio I.C., and Partridge E.E. An examination of acceptability of HPV vaccination among African American women and Latina immigrants. Journal of Women's Health 16 (2007) 1224-1233
41. Shah K., Daniel R., Tennant M., Shah N., McKee K.T., Gaydos C.A., et al. Diagnosis of human papillomavirus infection by dry vaginal swabs in military women. Sexually Transmitted Infections 77 (2001) 260-264
42. Shew M.L., Fortenberry D., Tu W., Juliar B.E., Batteiger B.E., Qadadri B., et al. Association of condom use, sexual behaviors, and sexually transmitted infections with the duration of genital human papillomavirus infection among adolescent women. Archives of Pediatrics and Adolescent Medicine 160 (2006) 151-156
43. Smith J.S., Munoz N., Herrero R., Eluf-Neto J., Ngelangel C., Franceschi S., et al. Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines. Journal of Infectious Diseases 185 (2002) 324-331
44. Stange K.C., Flocke S.A., Goodwin M.A., Kelly R.B., and Zyzanski S.J. Direct observation of rates of preventive service delivery in community family practice. Preventive Medicine 31 (2000) 167-176
45. Stange K.C., Goodwin M.A., Zyzanski S.J., and Dietrich A.J. Sustainability of a practice-individualized preventive service delivery intervention. American Journal of Preventive Medicine 25 (2003) 296-300
46. Tarkowski T.A., Koumans E.H., Sawyer M., Pierce A., Black C.M., Papp J.R., et al. Epidemiology of human papillomavirus infection and abnormal cytologic test results in an urban adolescent population. Journal of Infectious Diseases 189 (2004) 46-50
47. Villa L.L., Costa R.L., Petta C.A., Andrade R.P., Paavonen J., Iversen O.E., et al. High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up. British Journal of Cancer 95 (2006) 1459-1466
48. Weinstock H., Berman S., and Cates W. Sexually transmitted diseases among American youth: Incidence and prevalence estimates, 2000. Perspectives in Sexual and Reproductive Health 36 (2004) 6-10
49. Winer R.L., Hughes J.P., Feng Q., O'Reilly S., Kiviat N.B., Holmes K.K., et al. Condom Use and the Risk of Genital Human Papillomavirus Infection in Young Women. Obstetrical & Gynecological Survey 61 (2006) 639-640
50. Winer R.L., Lee S.K., Hughes J.P., Adam D.E., Kiviat N.B., and Koutsky L.A. Genital human papillomavirus infection: Incidence and risk factors in a cohort of female university students. American Journal of Epidemiology 157 (2003) 218-226
51. Wise P.H. The anatomy of a disparity in infant mortality. Annual Review of Public Health 24 (2003) 341-362
52. Wright T.C., Denny L., Kruhn L., Pollack A., and Lorincz A. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. Journal of the American Medical Association 283 (2000) 81-86
53. Young T.K., McNicol P., and Beauvais J. Factors associated with human papillomavirus infection detected by polymerase chain reaction among urban Canadian aboriginal and non-aboriginal women. Sexually Transmitted Diseases 24 (1997) 293-298
54. Zimet G.D. Improving adolescent health: Focus on HPV vaccine acceptance. Journal of Adolescent Health 37 (2005) S17-S23